BioCentury
ARTICLE | Clinical News

Ornithine phenylacetate: Phase I started

September 28, 2015 7:00 AM UTC

Ocera began an open-label, crossover Phase I trial to compare extended-release formulations of oral solid-dose OCR-002 vs. an immediate-release oral solution of OCR-002 and Ravicti glycerol phenylbut...